Fineline Cube

Follow:
14398 Articles
Regeneron Q4 Revenue Grows 3% to $3.9B on EYLEA HD and Dupixent Strength
Company

Regeneron Q4 Revenue Grows 3% to $3.9B on EYLEA HD and Dupixent Strength

Vcare Pharma Partners with Sun-Novo on VC005 JAK1 Inhibitor for Atopic Dermatitis
CompanyDeals

Vcare Pharma Partners with Sun-Novo on VC005 JAK1 Inhibitor for Atopic Dermatitis

Sciwind's Ecnoglutide Wins NMPA Nod as First cAMP‑Biased GLP‑1 Agonist
CompanyDrug

Sciwind’s Ecnoglutide Wins NMPA Nod as First cAMP‑Biased GLP‑1 Agonist

FDA Opens PreCheck Applications to Strengthen Domestic Drug Manufacturing
Policy / Regulatory

FDA Opens PreCheck Applications to Strengthen Domestic Drug Manufacturing

Ab&b Bio-Tech's Trivalent Influenza Vaccine Wins NMPA Nod for All Ages
CompanyDrug

Ab&b Bio-Tech’s Trivalent Influenza Vaccine Wins NMPA Nod for All Ages

Sanofi Rezurock Wins EU Backing for Graft‑Versus‑Host Disease
CompanyDrug

Sanofi Rezurock Wins EU Backing for Graft‑Versus‑Host Disease

CMS-D017 Gets NMPA Nod for PNH Clinical Trial
CompanyDrug

CMS-D017 Gets NMPA Nod for PNH Clinical Trial

J&J AKEEGA Gets CHMP Nod for BRCA-Mutated Prostate Cancer
CompanyDrug

J&J AKEEGA Gets CHMP Nod for BRCA-Mutated Prostate Cancer

Hengrui Ruitanning Gets NMPA Nod for Moderately Emetogenic Chemo Indication
CompanyDrug

Hengrui Ruitanning Gets NMPA Nod for Moderately Emetogenic Chemo Indication

CDE Seeks Feedback on 103rd Batch of Generic Reference Preparations
CompanyDrug

CDE Seeks Feedback on 103rd Batch of Generic Reference Preparations

Kyowa Kirin Reclaims Rocatinlimab Rights from Amgen in Strategic Shift
CompanyDeals

Kyowa Kirin Reclaims Rocatinlimab Rights from Amgen in Strategic Shift

Chiesi Fabry Drug Pegunigalsidase Alfa Wins CHMP Backing for Extended Dosing
CompanyDrug

Chiesi Fabry Drug Pegunigalsidase Alfa Wins CHMP Backing for Extended Dosing